Our novel tetra-specific T cell engager targeting CD33 x CD123 x CD70 x CD3
PIONEERING DARPin THERAPEUTICS
From radiopharmaceuticals to immune cell engagers, we are going beyond the limits of today’s leading treatments for cancer patients
Learn more >>